Tyra Biosciences Q2 EPS $(0.69) Misses $(0.65) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.65) by 6.15 percent. This is a 46.81 percent decrease over losses of $(0.47) per share
Tyra Biosciences lost more money per share than people expected, and its losses got bigger compared to last year. When a company's losses grow and miss what experts predicted, it's a sign to watch whether the business is moving toward profitability or if problems are getting worse.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.